analysis of treatment efficacy in the gem-cesar trial for high-risk smoldering multiple myeloma pts
Published 4 years ago • 238 plays • Length 5:22Download video MP4
Download video MP3
Similar videos
-
3:12
qip-mass spectrometry in high risk smoldering multiple myeloma pts included in the gem-cesar trial
-
2:30
curative strategy (gem-cesar) for high-risk smoldering myeloma (smm)
-
9:55
curative strategy for high-risk smoldering myeloma: post-hoc analysis of sustained undetectable mrd
-
4:19
qip-ms in high-risk myeloma patients in the gem-cesar trial
-
1:28
gem-cesar trial: post-hoc analysis of sustained undetectable mrd in patients with high-risk smm
-
4:04
how is high-risk smoldering multiple myeloma diagnosed?
-
4:48
curative strategy for smoldering multiple myeloma: gem-cesar
-
3:19
gem-cesar at eha 2019: curative treatment strategy for high-risk smoldering myeloma
-
3:53
comparison of mrd and conventional imwg response assessment in the gem-cesar trial
-
3:06
encouraging gem-cesar update: curative strategy for high-risk smoldering myeloma
-
4:47
what is high-risk smoldering myeloma? criteria, risks, and ongoing research
-
59:27
imwg conference series: reporting from ash 2022
-
4:20
what were the results of the determination trial presented at asco and eha?
-
59:53
clinical trials in multiple myeloma
-
4:12
when should smoldering multiple myeloma patients start treatment?
-
1:17:50
clinical trials for high risk smoldering myeloma patients
-
2:01
ash 2019: high-risk smoldering myeloma treatment research | dr. irene ghobrial
-
2:50
is the imf’s ascent trial curing smoldering myeloma patients?
-
3:36
how do multiple myeloma experts define cure?